Mark Bain

658 total citations
11 papers, 537 citations indexed

About

Mark Bain is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Bain has authored 11 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Mark Bain's work include Cytomegalovirus and herpesvirus research (8 papers), Herpesvirus Infections and Treatments (5 papers) and Virus-based gene therapy research (3 papers). Mark Bain is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Herpesvirus Infections and Treatments (5 papers) and Virus-based gene therapy research (3 papers). Mark Bain collaborates with scholars based in United Kingdom. Mark Bain's co-authors include John Sinclair, Martin J. Allday, Paul J. Farrell, Mark R. Wills, J. G. P. Sissons, Elizabeth Sara, Gillian A. Parker, Marc Mendelson, Martin Rowe and Michelle J. West and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of General Virology.

In The Last Decade

Mark Bain

11 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bain United Kingdom 11 311 276 128 110 99 11 537
Diego Illanes United States 8 305 1.0× 424 1.5× 134 1.0× 165 1.5× 149 1.5× 9 612
Mathias Thurau Germany 14 306 1.0× 306 1.1× 135 1.1× 156 1.4× 27 0.3× 16 535
Stacy R. Hagemeier United States 11 227 0.7× 395 1.4× 171 1.3× 120 1.1× 115 1.2× 13 549
Anja M. Mehl United Kingdom 8 167 0.5× 238 0.9× 73 0.6× 233 2.1× 124 1.3× 11 482
Horng-Shen Chen United States 11 356 1.1× 470 1.7× 151 1.2× 113 1.0× 116 1.2× 12 647
Slavoljub Milosevic Germany 9 233 0.7× 258 0.9× 133 1.0× 326 3.0× 22 0.2× 13 583
J S Pagano Germany 13 383 1.2× 458 1.7× 84 0.7× 112 1.0× 155 1.6× 21 720
Anita Koroknai Hungary 14 103 0.3× 226 0.8× 114 0.9× 68 0.6× 61 0.6× 25 435
Geoff Connolly Australia 11 161 0.5× 358 1.3× 120 0.9× 240 2.2× 117 1.2× 12 533
Susan M. Turk United States 6 434 1.4× 575 2.1× 39 0.3× 237 2.2× 165 1.7× 8 750

Countries citing papers authored by Mark Bain

Since Specialization
Citations

This map shows the geographic impact of Mark Bain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bain more than expected).

Fields of papers citing papers by Mark Bain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bain. The network helps show where Mark Bain may publish in the future.

Co-authorship network of co-authors of Mark Bain

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bain. A scholar is included among the top collaborators of Mark Bain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bain. Mark Bain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Poole, Emma, et al.. (2012). The Cellular Protein MCM3AP Is Required for Inhibition of Cellular DNA Synthesis by the IE86 Protein of Human Cytomegalovirus. PLoS ONE. 7(10). e45686–e45686. 10 indexed citations
2.
Jafferji, Insiya, Mark Bain, Christine A. King, & John Sinclair. (2009). Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoter. Journal of General Virology. 90(7). 1569–1574. 17 indexed citations
3.
Bain, Mark & John Sinclair. (2007). The S phase of the cell cycle and its perturbation by human cytomegalovirus. Reviews in Medical Virology. 17(6). 423–434. 29 indexed citations
5.
Wright, Edward, et al.. (2005). Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells. Journal of General Virology. 86(3). 535–544. 51 indexed citations
6.
Bain, Mark, Marc Mendelson, & John Sinclair. (2003). Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells. Journal of General Virology. 84(1). 41–49. 44 indexed citations
7.
Sissons, J. G. P., Mark Bain, & Mark R. Wills. (2002). Latency and Reactivation of Human Cytomegalovirus. Journal of Infection. 44(2). 73–77. 76 indexed citations
8.
Fairley, Janet A., J. Baillie, Mark Bain, & John Sinclair. (2002). Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors. Journal of General Virology. 83(11). 2803–2810. 37 indexed citations
9.
Bain, Mark, et al.. (1997). Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. Journal of Virology. 71(11). 8552–8562. 87 indexed citations
10.
Bain, Mark, R J Watson, Paul J. Farrell, & Martin J. Allday. (1996). Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. Journal of Virology. 70(4). 2481–2489. 57 indexed citations
11.
Parker, Gillian A., et al.. (1996). Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.. PubMed. 13(12). 2541–9. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026